DaVita Inc. (DVA), 3SBio Inc. (SSRX) Partner to Provide Kidney Care in NE China  
3/9/2012 6:06:26 AM

DENVER & SHENYANG, China--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD) today announced it has entered into an agreement with 3SBio Inc., a leading Chinese biotechnology developer of biopharmaceutical products, to establish a joint venture for providing dialysis treatments in northeastern China.